Abrdn Aktie
2,28
EUR
+0,04
EUR
+1,79
%
2,04
GBP
+0,05
GBP
+2,62
%
Werbung
Abrdn Aktie Analyse
| 21.01.13 | Abrdn Current Investment List | Goldman Sachs Group Inc. | |
| 28.11.12 | Abrdn outperform | Exane-BNP Paribas SA | |
| 22.11.12 | Abrdn overweight | J.P. Morgan Cazenove | |
| 19.11.12 | Abrdn outperform | Exane-BNP Paribas SA | |
| 02.11.12 | Abrdn outperform | Exane-BNP Paribas SA | |
| 09.10.12 | Abrdn outperform | Exane-BNP Paribas SA | |
| 08.10.12 | Abrdn overweight | J.P. Morgan Cazenove | |
| 14.09.12 | Abrdn outperform | Exane-BNP Paribas SA | |
|
Werbung
|
|||
| 03.09.12 | Abrdn overweight | J.P. Morgan Cazenove | |
| 30.08.12 | Abrdn overweight | J.P. Morgan Cazenove | |
| 29.08.12 | Abrdn overweight | J.P. Morgan Cazenove | |
| 24.08.12 | Abrdn outperform | Exane-BNP Paribas SA | |
| 15.08.12 | Abrdn outperform | Exane-BNP Paribas SA | |
Werbung
Werbung